carboxyebselen has been researched along with 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione in 2 studies
| Studies (carboxyebselen) | Trials (carboxyebselen) | Recent Studies (post-2010) (carboxyebselen) | Studies (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) | Trials (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) | Recent Studies (post-2010) (4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione) |
|---|---|---|---|---|---|
| 6 | 0 | 5 | 126 | 1 | 84 |
| Protein | Taxonomy | carboxyebselen (IC50) | 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione (IC50) |
|---|---|---|---|
| [tau protein] kinase | Oryctolagus cuniculus (rabbit) | 2 | |
| G2/mitotic-specific cyclin-B2 | Homo sapiens (human) | 10 | |
| Cyclin-dependent kinase 1 | Homo sapiens (human) | 10 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome-related coronavirus | 2.15 | |
| Replicase polyprotein 1ab | Severe acute respiratory syndrome coronavirus 2 | 1.145 | |
| G2/mitotic-specific cyclin-B1 | Homo sapiens (human) | 10 | |
| Glycogen synthase kinase-3 alpha | Homo sapiens (human) | 4.5 | |
| Glycogen synthase kinase-3 beta | Homo sapiens (human) | 2.0608 | |
| G2/mitotic-specific cyclin-B3 | Homo sapiens (human) | 10 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 2 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, J; Gao, K; Huang, F; Tepe, JJ; Wang, R; Wei, GW | 1 |
| Cao, H; Chen, H; Han, X; Huang, Y; Liu, J; Peng, C; Rao, L; Ren, Y; Sheng, C; Su, C; Tu, J; Wan, C; Wan, J; Wen, W | 1 |
2 other study(ies) available for carboxyebselen and 4-benzyl-2-methyl-1,2,4-thiadiazolidine-3,5-dione
| Article | Year |
|---|---|
Perspectives on SARS-CoV-2 Main Protease Inhibitors.
Topics: Antiviral Agents; Coronavirus 3C Proteases; Humans; Protease Inhibitors | 2021 |
Structure-Guided Discovery of the Novel Covalent Allosteric Site and Covalent Inhibitors of Fructose-1,6-Bisphosphate Aldolase to Overcome the Azole Resistance of
Topics: Allosteric Site; Antifungal Agents; Azoles; Biofilms; Candida albicans; Candida parapsilosis; Drug Resistance, Fungal; Enzyme Inhibitors; Fructose-Bisphosphate Aldolase; Fungal Proteins; Microbial Sensitivity Tests; Molecular Structure; Protein Binding; Structure-Activity Relationship | 2022 |